Literature DB >> 22709796

Risk of vascular disease in patients with multiple sclerosis: a review.

Christian Fynbo Christiansen1.   

Abstract

OBJECTIVE: Vascular dysfunction and shared risk factors may lead to an increased risk of arterial and venous vascular disease in patients with multiple sclerosis (MS). The aim of this review was to describe studies examining the risk of vascular diseases in MS patients.
METHODS: A PubMed search combined with review of reference lists and table of contents revealed eight relevant studies describing the occurrence or risk of one or more vascular diseases.
RESULTS: One cohort study and three cross-sectional studies described stroke occurrence in 898 to 13 963 MS patients. MS was associated with an increased risk of stroke and cerebrovascular diseases compared with the general population and other hospitalized patients, particularly within the first years after MS diagnosis and in young and middle-aged MS patients. In contrast, data are conflicting with regard to the association between MS and coronary artery disease including myocardial infarction. Cross-sectional studies found a lower prevalence of coronary artery disease in MS patients, while the only cohort study found an increased risk within the first year after MS diagnosis only. MS was, however, associated with an increased risk of venous thromboembolism, including deep venous thromboembolism and pulmonary embolism, in particular within the first years after MS diagnosis. DISCUSSION: MS is associated with an increased risk of vascular diseases within the first years after a first-time MS diagnosis compared with the general population. The risk declines thereafter, but remains elevated for stroke and venous thromboembolism. Shared risk factors, linked pathogenesis, and bias may contribute to the association.

Entities:  

Mesh:

Year:  2012        PMID: 22709796     DOI: 10.1179/1743132812Y.0000000051

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  14 in total

1.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

Review 2.  Autonomic dysfunction, immune regulation, and multiple sclerosis.

Authors:  Juan Manuel Racosta; Kurt Kimpinski
Journal:  Clin Auton Res       Date:  2015-12-21       Impact factor: 4.435

3.  Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis.

Authors:  Tomaž Omerzu; Jožef Magdič; Radovan Hojs; Uroš Potočnik; Mario Gorenjak; Tanja Hojs Fabjan
Journal:  Wien Klin Wochenschr       Date:  2021-04-26       Impact factor: 1.704

Review 4.  Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.

Authors:  Vladimir V Bamm; Arielle M Geist; George Harauz
Journal:  Metab Brain Dis       Date:  2016-11-02       Impact factor: 3.584

5.  Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis.

Authors:  Dragana Drobnjak Nes; Pål Berg-Hansen; Sigrid A de Rodez Benavent; Einar A Høgestøl; Mona K Beyer; Daniel A Rinker; Nina Veiby; Mia Karabeg; Beáta Éva Petrovski; Elisabeth G Celius; Hanne F Harbo; Goran Petrovski
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

6.  Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis.

Authors:  P Belov; D Jakimovski; J Krawiecki; C Magnano; J Hagemeier; L Pelizzari; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

Review 7.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

8.  Five-Year Longitudinal Study of Neck Vessel Cross-Sectional Area in Multiple Sclerosis.

Authors:  L Pelizzari; D Jakimovski; M M Laganà; N Bergsland; J Hagemeier; G Baselli; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2018-07-26       Impact factor: 3.825

Review 9.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

Review 10.  Aspirin and multiple sclerosis.

Authors:  Sheila Tsau; Mitchell R Emerson; Sharon G Lynch; Steven M LeVine
Journal:  BMC Med       Date:  2015-06-29       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.